BARCELONA, Spain--(BUSINESS WIRE)--Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems, has announced that it has received conditional IDE approval from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback